Association between low serum zinc concentration and newly recorded osteoporosis with pathological fracture among adults aged 50 years and older
Background Zinc is essential for bone remodeling, yet longitudinal evidence linking circulating zinc to subsequently recorded osteoporosis-related skeletal outcomes remains limited. We examined whether low serum zinc was associated with these outcomes in adults aged ≥50 years. Methods This retrospective multicenter cohort study used the TriNetX Global Collaborative Network. Patients with serum or plasma zinc <0.70 μg/mL were compared with those within 0.70–1.20 μg/mL. Patients who died or had a qualifying skeletal event during days 1–90 after index were excluded (landmark analysis); follow-up ran from day 91 through year 6. After propensity score matching, 32,524 patients remained in each group. Cox proportional-hazards models assessed the first recorded diagnosis of osteoporosis with current pathological fracture (M80) and exploratory secondary skeletal outcomes. A supplementary unmatched competing-risk analysis treated death as a competing event. Results A newly recorded M80 diagnosis occurred in 310 patients (0.95%) with low zinc and 217 controls (0.67%), an absolute difference of 0.29 percentage points (hazard ratio [HR] = 1.52; 95% confidence interval, 1.28–1.81). Exploratory secondary analyses showed higher hazards of the major osteoporotic-site fracture composite (HR = 1.24), femoral fracture (HR = 1.34), pelvic fracture (HR = 1.45), and osteoporosis without current pathological fracture (HR = 1.25); all-cause mortality was also higher (HR = 1.43). Sensitivity analyses yielded directionally consistent primary-outcome estimates. In an exploratory alternative-exposure analysis, severe zinc deficiency was associated with a higher primary-outcome hazard (HR = 2.16). The unmatched competing-risk analysis was directionally similar but provided no matched estimate. Conclusion Low circulating zinc was associated with a higher hazard of a newly recorded M80 diagnosis and with exploratory site-based skeletal outcomes in this selected zinc-tested population. The modest absolute event-proportion difference, residual confounding, higher mortality, and diagnostic-coding limitations preclude causal, screening, or treatment inferences. Low zinc may reflect broader physiological vulnerability rather than an actionable skeletal risk factor; prospective studies are needed to clarify its clinical significance.
Authors
- Kuo‐Mao Lan (ORCID: https://orcid.org/0000-0001-5489-0350)
- Wei-Ting Wang (ORCID: https://orcid.org/0009-0003-0681-9316)
- Yu-Li Pang
- Shu-Wei Liao (ORCID: https://orcid.org/0000-0001-9109-2331)
- Ying-Jen Chang
Institutions
- E-Da Hospital (TW)
- Chi Mei Medical Center (TW)
- Chia Nan University of Pharmacy and Science (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fnut.2026.2026242
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00